GlassScriptPhysician profile
Dawn T Bircher
NPI 1235137308
$4,491.54
in general payments reported to CMS, 2019-2025
29 companies · $922 in 2025
The $922 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $224 · 2021: $224 · 2022: $597 · 2023: $624 · 2024: $829 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,374.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $537.20 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $443.55 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Dompe US, INC. | $330.67 | 2019-2025 | Oxervate |
| Alcon Vision LLC | $324.63 | 2020-2025 | Tryptyr, Rocklatan, Clareon |
| Sun Pharmaceutical Industries INC. | $322.81 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $316.63 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $314.84 | 2022-2025 | Tyrvaya, Ryzumvi |
| Coopervision INC. | $263.62 | 2019-2023 | Onefit Contact Lens, Myday Contact Lens |
| Biotissue Holdings INC. | $239.03 | 2019-2024 | |
| Horizon Therapeutics Plc | $224.49 | 2022-2023 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $217.67 | 2020-2025 | |
| Lkc Technologies, INC. | $201.44 | 2024-2025 | |
| Kala Pharmaceuticals, INC. | $145.65 | 2019-2022 | |
| Synergeyes, INC. | $108.30 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $82.72 | 2019-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $79.24 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $69.64 | 2020-2021 | |
| Thea Pharma INC. | $48.63 | 2022-2023 | Iyuzeh |
| Harrow Eye, LLC | $33.55 | 2024 | Vevye |
| Abb Con-Cise Optical Group LLC | $31.72 | 2023-2025 | Contact Lens, Spectacle Lenses |
| Carl Zeiss Meditec USA, INC. | $30.62 | 2022 | |
| Shire North American Group INC | $20.19 | 2019 | |
| Amgen INC. | $18.46 | 2024 | Tepezza |
| Genzyme Corporation | $17.91 | 2019 | |
| Rxsight INC | $17.63 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Abbvie INC. | $13.87 | 2022 | |
| Eyevance Pharmaceuticals LLC | $13.38 | 2019 | |
| Alcon Research LLC | $12.11 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Bircher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.